166 related articles for article (PubMed ID: 11875716)
1. Src tyrosine kinase augments taxotere-induced apoptosis through enhanced expression and phosphorylation of Bcl-2.
Boudny V; Nakano S
Br J Cancer; 2002 Feb; 86(3):463-9. PubMed ID: 11875716
[TBL] [Abstract][Full Text] [Related]
2. Src tyrosine kinase but not activated Ras augments sensitivity to taxanes through apoptosis in human adenocarcinoma cells.
Boudny V; Nakano S
Anticancer Res; 2003; 23(1A):7-12. PubMed ID: 12680188
[TBL] [Abstract][Full Text] [Related]
3. v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells.
Masumoto N; Nakano S; Fujishima H; Kohno K; Niho Y
Int J Cancer; 1999 Mar; 80(5):731-7. PubMed ID: 10048975
[TBL] [Abstract][Full Text] [Related]
4. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
[TBL] [Abstract][Full Text] [Related]
5. Src kinase and PI 3-kinase as a transduction pathway in ceramide-induced contraction of colonic smooth muscle.
Ibitayo AI; Tsunoda Y; Nozu F; Owyang C; Bitar KN
Am J Physiol; 1998 Oct; 275(4):G705-11. PubMed ID: 9756500
[TBL] [Abstract][Full Text] [Related]
6. Direct tumorigenic conversion of human gallbladder carcinoma cells by v-src but not by activated c-H-ras oncogene.
Tatsumoto T; Nakano S; Shimizu K; Ono M; Esaki T; Ohshima K; Niho Y
Int J Cancer; 1995 Apr; 61(2):206-13. PubMed ID: 7705949
[TBL] [Abstract][Full Text] [Related]
7. Activation and the interaction of proapoptotic genes in modulating sensitivity to anticancer drugs in gastric cancer cells.
Kim R; Ohi Y; Inoue H; Toge T
Int J Oncol; 1999 Oct; 15(4):751-6. PubMed ID: 10493958
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways.
Esparza J; Vilardell C; Calvo J; Juan M; Vives J; Urbano-Márquez A; Yagüe J; Cid MC
Blood; 1999 Oct; 94(8):2754-66. PubMed ID: 10515879
[TBL] [Abstract][Full Text] [Related]
9. G protein beta gamma subunits stimulate phosphorylation of Shc adapter protein.
Touhara K; Hawes BE; van Biesen T; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9284-7. PubMed ID: 7568118
[TBL] [Abstract][Full Text] [Related]
10. Ornithine decarboxylase- and ras-induced cell transformations: reversal by protein tyrosine kinase inhibitors and role of pp130CAS.
Auvinen M; Paasinen-Sohns A; Hirai H; Andersson LC; Hölttä E
Mol Cell Biol; 1995 Dec; 15(12):6513-25. PubMed ID: 8524216
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of thrombin-induced MAPK activation associated with cell proliferation in human cultured tracheal smooth muscle cells.
Lin CC; Shyr MH; Chien CS; Wang CC; Chiu CT; Hsiao LD; Yang CM
Cell Signal; 2001 Apr; 13(4):257-67. PubMed ID: 11306243
[TBL] [Abstract][Full Text] [Related]
12. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
Murakami Y; Fukazawa H; Mizuno S; Uehara Y
Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitors reduce bcl-2 expression and induce apoptosis in androgen-dependent cells.
Ohigashi T; Ueno M; Nonaka S; Nakanoma T; Furukawa Y; Deguchi N; Murai M
Am J Physiol Cell Physiol; 2000 Jan; 278(1):C66-72. PubMed ID: 10644513
[TBL] [Abstract][Full Text] [Related]
14. v-Src suppresses SHPS-1 expression via the Ras-MAP kinase pathway to promote the oncogenic growth of cells.
Machida K; Matsuda S; Yamaki K; Senga T; Thant AA; Kurata H; Miyazaki K; Hayashi K; Okuda T; Kitamura T; Hayakawa T; Hamaguchi M
Oncogene; 2000 Mar; 19(13):1710-8. PubMed ID: 10763828
[TBL] [Abstract][Full Text] [Related]
15. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
Maruyama T; Yamamoto Y; Shimizu A; Masuda H; Sakai N; Sakurai R; Asada H; Yoshimura Y
Biol Reprod; 2004 Jan; 70(1):214-21. PubMed ID: 14522827
[TBL] [Abstract][Full Text] [Related]
16. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation.
Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM
Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205
[TBL] [Abstract][Full Text] [Related]
17. Activation of the Ras signaling pathway by the CD40 receptor.
Gulbins E; Brenner B; Schlottmann K; Koppenhoefer U; Linderkamp O; Coggeshall KM; Lang F
J Immunol; 1996 Oct; 157(7):2844-50. PubMed ID: 8816388
[TBL] [Abstract][Full Text] [Related]
18. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
[TBL] [Abstract][Full Text] [Related]
19. Differential anti-tumor activities of curcumin against Ras- and Src-activated human adenocarcinoma cells.
Ono M; Higuchi T; Takeshima M; Chen C; Nakano S
Biochem Biophys Res Commun; 2013 Jun; 436(2):186-91. PubMed ID: 23726918
[TBL] [Abstract][Full Text] [Related]
20. UCS15A, a non-kinase inhibitor of Src signal transduction.
Sharma SV; Oneyama C; Yamashita Y; Nakano H; Sugawara K; Hamada M; Kosaka N; Tamaoki T
Oncogene; 2001 Apr; 20(17):2068-79. PubMed ID: 11360191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
